Task: Answer the multiple-choice question.
Question: Which drug exhibits a -1.408% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a Cc1ccc(/C=N/N=C/c2ccc(C)s2)s1
b CC(=O)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1
c Cc1cc(Nc2ccccc2)n(-c2ccc(C(=O)O)cc2)n1
d Cn1c(SCC(=O)c2ccccc2)nnc1C1CC1
Answer: d. Cn1c(SCC(=O)c2ccccc2)nnc1C1CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(SCC(=O)c2ccccc2)nnc1C1CC1
Cn1c(SCC(=O)c2ccccc2)nnc1C1CC1
2-[(5-cyclopropyl-4-methyl-1,2,4-triazol-3-yl)sulfanyl]-1-phenylethanone